Question · asked by 1 review
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs placebo or no treatment: Patient quality of life
- Population
- Patients with cancer receiving chemotherapy and/or radiotherapy
- Intervention
- Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole)
- Comparison
- placebo or no treatment
- Outcome
- Patient quality of life
The review found no eligible studies for this question.
What each review found
Current versions onlyNo studies found 3 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment Patient quality of life · Patients with cancer receiving chemotherapy or radiotherapy or both The review found no eligible studies for this question. Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2007) · Cochrane All outcomes | No trial reported this planned secondary outcome for any comparison in this review | Not reported | No studies found |
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment Patient quality of life · Patients with cancer receiving chemotherapy and/or radiotherapy The review found no eligible studies for this question. Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2004) · Cochrane All outcomesearlier version CD003807.PUB2, superseded | No trial reported this planned secondary outcome for any comparison in this review | Not reported | No studies found |
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs Placebo or no treatment Patient quality of life · Patients with cancer receiving chemotherapy and/or radiotherapy The review found no eligible studies for this question. Interventions for preventing oral candidiasis for patients with cancer receiving treatment (2002) · Cochrane All outcomesearlier version CD003807, superseded | No trial reported this planned secondary outcome for any comparison in this review | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for preventing oral candidiasis for patients with cancer receiving treatment 2007 · Cochrane All outcomes | 2009-08 | Not listed | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.